PureTech Health (PRTC)
NASDAQ:PRTC
Holding PRTC?
Track your performance easily

PureTech Health (PRTC) Income Statement

28 Followers

PureTech Health Income Statement

Last quarter (Q2 2022), PureTech Health's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, PureTech Health's net income was $―. See PureTech Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 750.00K$ 15.62M$ 9.98M$ 8.34M$ 9.81M
Cost of Revenue
------
Gross Profit
-$ 3.33M$ 15.62M---
Operating Expense
-$ 146.95M$ 213.42M$ -160.26M$ 127.87M$ 145.21M
Operating Income
-$ -146.20M$ -197.81M$ -150.28M$ -119.53M$ -135.40M
Net Non Operating Interest Income Expense
-$ 2.52M$ 9.75M$ 4.50M$ 1.76M$ -260.00K
Other Income Expense
-$ -107.67M$ -159.41M---
Pretax Income
-$ -36.10M$ -37.02M$ -58.95M$ 18.97M$ 478.47M
Tax Provision
-$ 30.52M$ 55.72M$ -3.76M$ 14.40M$ 112.41M
Earnings From Equity Interest Net Of Tax
-$ -6.05M$ 471.00K---
Net Income Common Stockholders
-$ -65.70M$ -79.45M$ -60.56M$ 5.99M$ 421.14M
Basic EPS
-$ -0.24$ -0.18$ -0.21$ 0.02$ 1.49
Diluted EPS
-$ -0.24$ -0.18$ -0.21$ 0.02$ 1.44
Basic Average Shares
-$ 276.30M$ 284.76M$ 286.59M$ 285.60M$ 283.43M
Diluted Average Shares
-$ 276.30M$ 284.76M$ 286.59M$ 292.86M$ 291.78M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-$ 146.95M$ 213.42M$ -160.26M$ -127.87M$ -145.21M
Net Income From Continuing And Discontinued Operation
-$ -65.70M$ -79.45M$ -60.56M$ 5.99M$ 421.14M
Normalized Income
-$ -27.08M$ -21.60M-$ 15.39M$ -279.41M
Interest Expense
------
EBIT
-$ -22.61M$ -40.97M$ -63.45M$ 21.91M$ 481.12M
EBITDA
-$ -17.68M$ -32.08M$ -63.45M$ 21.91M$ 481.12M
Currency in USD

PureTech Health Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis